Lipedema (Lipoedema) denials in California external review

In the California DMHC record, independent physician reviewers decided 27 published external-review cases involving lipedema (lipoedema)and overturned the plan’s denial in 44.4%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
27
2022–2025
Overturned
44.4%
12 denials reversed

Most-fought treatments for lipedema (lipoedema)

What insurers denied — and how those fights ended.
CategoryDecisionsOverturned
Liposuction19
42.1%
Typical time to a decision
19 days
Most land between 7 and 21 days
Handled as urgent
33.3%
Expedited when a delay would cause harm

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for suction assisted lipectomy of the bilateral arms and bilateral legs with associated hospitalization.Researchers report that lipedema is believed to affect 11% to 39% of the female Caucasian population worldwide, and that as many as 16 million women in the United States may be affected with the disorder. Researchers state, “Lipedema is an uncommon disorder characterized by localized adiposity of the lower extremities, often occurring in females with a family history of the condition. The adiposity extends from hips to ankles and is typically unresponsive to weight loss. In addition to the aesthetic deformity, women also describe pain in the lower extremities, particularly with pressure, as well as easy bruising.
Medical Necessity · 2023 · IMR MN23-39962
Findings: The physician reviewer found that Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for suction-assisted lipectomy to remove fat and other tissues of the trunk and arms. Lipedema is a chronic, progressive disorder of subcutaneous adipose tissue that usually affects the lower extremities. The benefits of suction lipectomy for the treatment of patients with lipedema are well established. These benefits include better ambulation and quality of life, and improvement in pain and tenderness. One study collected data from women who had undergone lipedema reduction surgery to determine if they experienced improvement in their quality of life, pain, and other measures.
Medical Necessity · 2023 · IMR MN23-40527

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for lipedema surgery- suction assisted lipectomy to posterior hips and buttocks with excision of skin excess and thigh nodule, lateral thigh liposuction to address nodules in the lateral thigh, medial thigh and medial calf and excision of excess medial thigh skin are not reconstructive in nature for the treatment of this patient. One study stated that lipedema is an uncommon disorder characterized by localized adiposity of the lower extremities, often occurring in females with a family history of the condition. The adiposity extends from hips to ankles and is typically unresponsive to weight loss. In addition to the aesthetic deformity, patients also describe pain in the lower extremities, particularly with pressure, as well as easy bruising.
Medical Necessity · 2024 · IMR MN24-41529
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for additional lipedema reduction surgeries consisting of suction-assisted lipectomy of the (1) circumferential torso; (2) calves/ankles/upper arms; and (3) circumferential thighs. Sandhofer and colleagues report that lipedema is believed to affect 11% to 39% of the female Caucasian population worldwide, and that as many as 16 million women in the United States may be affected with the disorder. Warren Peled and Kappos state, “Lipedema is an uncommon disorder characterized by localized adiposity of the lower extremities, often occurring in females with a family history of the condition. The adiposity extends from hips to ankles and is typically unresponsive to weight loss.
Medical Necessity · 2022 · IMR MN22-37602

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving lipedema (lipoedema), then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for lipedema (lipoedema)? Use the California record to prepare.

Explain my denial — freeStart my appeal · $9